✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Aristo Bio-Tech and Lifescience Ltd.

ARISTO

Market Cap
₹97 Cr.
P/E
23.79

Aristo Bio-Tech and Lifescience Ltd.

  • Aristo Bio-Tech&Lis
  • Ambey Laboratories
  • Crop Life Science
FAQs on Aristo Bio-Tech and Lifescience Ltd. Shareprice

Aristo Bio-Tech&Lis has given better returns compared to its competitors.
Aristo Bio-Tech&Lis has grown at ~46.39% over the last 1yrs while peers have grown at a median rate of 1.0%

Aristo Bio-Tech&Lis is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Aristo Bio-Tech&Lis is 23.79, while 3 year average PE is 17.57.
Also latest EV/EBITDA of Aristo Bio-Tech&Lis is 0 while 3yr average is 7.27.

View FAQ's On Business
Growth Table
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Balance Sheet
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Cash Flow
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Quarterly Results
  • Aristo Bio-Tech and Lifescience Ltd.
  • Ambey Laboratories
  • Crop Life Science
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Aristo Bio-Tech and Lifescience Ltd. Financials

Balance sheet of Aristo Bio-Tech&Lis is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Aristo Bio-Tech&Lis is increasing.
Latest net debt of Aristo Bio-Tech&Lis is ₹20.74 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹19.6 Crs.

Yes, profit is increasing.
The profit of Aristo Bio-Tech&Lis is ₹4.06 Crs for TTM, ₹3.9 Crs for Mar 2024 and ₹3.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aristo Bio-Tech&Lis latest dividend payout ratio is 6.99% and 3yr average dividend payout ratio is 5.88%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech